Evidence map›Paper›PMID 32155797›Full record

ArticleFoods (Basel, Switzerland)2020

Anticancer Activities of Meroterpenoids Isolated from the Brown Alga

Hanaa Zbakh, Eva Zubía, Carolina De Los Reyes, José M Calderón-Montaño, Virginia Motilva

Open access · goldAbstract read
In one paragraph

Article in Foods (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
3.5field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 24 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Allelochemicals from the seaweeds and their bioprospecting potential.Naunyn-Schmiedeberg's archives of pharmacology · 2024
    Review
  6. Meroterpenoids fromPharmaceuticals (Basel, Switzerland) · 2023
    Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Hanaa ZbakhDepartment of Pharmacology, Faculty of Pharmacy, University of Seville, 41012 Seville, Spain.
Eva ZubíaDepartment of Organic Chemistry, Faculty of Marine and Environmental Sciences, University of Cadiz, 11510 Puerto Real (Cádiz), Spain.
Carolina De Los ReyesDepartment of Organic Chemistry, Faculty of Marine and Environmental Sciences, University of Cadiz, 11510 Puerto Real (Cádiz), Spain.
José M Calderón-MontañoDepartment of Pharmacology, Faculty of Pharmacy, University of Seville, 41012 Seville, Spain.ORCID 0000-0001-6845-797X
Virginia MotilvaDepartment of Pharmacology, Faculty of Pharmacy, University of Seville, 41012 Seville, Spain.
Universidad de Cádiz · ESUniversidad de Sevilla · ESAbdelmalek Essaâdi University · MA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Colorectal cancer (CRC) is one of the most common types of cancers and a leading cause of cancer death worldwide. The current treatment for CRC mainly involves surgery, radiotherapy, and chemotherapy. However, due to the side effects and the emergence of drug resistance, the search for new anticancer agents, pharmacologically safe and effective, is needed. In the present study, we have investigated the anticancer effects of eight algal meroterpenoids (AMTs,

Indexed as

apoptosiscell cyclecolon cancerCystoseira usneoidesHT-29meroterpenoidsmetastasis

Identifiers

PMID32155797
PMCPMC7143549
OpenAlexW3010126323

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.